Autoinflammation in 2010: expanding clinical spectrum and broadening therapeutic horizons.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21289614.
- Also identified by DOI 10.1038/nrrheum.2010.229 and PMC identifier 3393888.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 2010, important research into the systemic autoinflammatory diseases has confirmed and extended the role of IL-1 inhibition in hereditary autoinflammatory disorders, demonstrated a novel treatment for a dangerous complication, and expanded the spectrum of systemic autoinflammatory diseases while further implicating autoinflammation in the pathophysiology of the metabolic syndrome.
Medical subject headings
- Antirheumatic Agents
- Hereditary Autoinflammatory Diseases
- Interleukin 1 Receptor Antagonist Protein